A Nasal Spray Combining Camostat with a Natural Polysaccharide for the Prevention of Viral Infection via Nasal Mucosal Barrier Formation and Entry Inhibition
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27021053 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Yujeong Na und 10 weiteren Autor:innen. Beteiligte Einrichtung: Daewoong Pharmaceutical Co., Ltd., 72 Dugye-ro, Pogok-eup, Cheoin-gu, Yongin-si 17028, Gyeonggi-do, Republic of Korea. Hauptthemen laut MEDLINE: Nasal Sprays, Polysaccharides, Bacterial, Nasal Mucosa, Antiviral Agents. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In recent years, numerous researchers have investigated various preventive strategies against respiratory viruses that pose a threat to human health. This study aims to develop a nasal spray formulation based on the natural polysaccharide xanthan gum (XG) and camostat, and to evaluate its dual protective mechanism at the nasal mucosa, the primary entry point for respiratory viral infections. The efficacy of the formulation was assessed through physicochemical characterization, cell-based assays, and animal experiments. Initially, muco-adhesiveness was evaluated by monitoring the drying dispersion area of the test formulation over time on a Petri dish. The combination of XG and camostat exhibited a dispersion area more than ten times larger than that of each component used alone. The antiviral efficacy was demonstrated in both human nasal epithelial cells (HNEc) and an influenza-infected mouse model. The cell-based experiment demonstrated a significant inhibition of viral penetration and replication. Furthermore, suppression of transmembrane protease, serine 2 (TMPRSS2) expression, a key factor in influenza virus entry, was observed in mouse lung tissues. These findings suggest that the Camostat–Polysaccharide Dual-Action Nasal Spray (CPNS), currently under development, holds promise as a non-invasive, first-line barrier to prevent the initial infection and replication of respiratory viruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Daewoong Pharmaceutical Co., Ltd., 72 Dugye-ro, Pogok-eup, Cheoin-gu, Yongin-si 17028, Gyeonggi-do, Republic of Korea.
- CGBIO Co., Ltd., 52 Sagimakgol-ro, Jungwon-gu, Seongnam-si 13215, Gyeonggi-do, Republic of Korea.
- College of Veterinary Medicine, Biosafety Research Institute and Core Facility Center for Zoonosis Research, Jeonbuk National University, 79 Gobong-ro, Iksan 54596, Jeollabuk-do, Republic of Korea.
- Department of Biohealth, Kunsan National University, 558 Daehak-ro, Gunsan 54150, Jeollabuk-do, Republic of Korea.
ORCID-Profile: Byeongyong Kim, Gwanyoung Kim
Zitieren
APA
Na, Y., Kim, B., Lee, D., Choi, J., Cho, S., Lee, K., Kim, G., Cho, E., Kim, J., Eo, S. K., & Kim, S. (2026). A Nasal Spray Combining Camostat with a Natural Polysaccharide for the Prevention of Viral Infection via Nasal Mucosal Barrier Formation and Entry Inhibition. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27021053
Vancouver
Na Y, Kim B, Lee D, Choi J, Cho S, Lee K, et al. A Nasal Spray Combining Camostat with a Natural Polysaccharide for the Prevention of Viral Infection via Nasal Mucosal Barrier Formation and Entry Inhibition. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27021053
BibTeX
@article{Na2026,
author = {Na, Yujeong and Kim, Byeongyong and Lee, Dongjin and Choi, Jongseo and Cho, Sangeun and Lee, Kyungmin and Kim, Gwanyoung and Cho, Eunyoung and Kim, Jonggeun and Eo, Seong Kug and Kim, Sokho},
title = {A Nasal Spray Combining Camostat with a Natural Polysaccharide for the Prevention of Viral Infection via Nasal Mucosal Barrier Formation and Entry Inhibition},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27021053}
}
EUVIMED